Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Ezequiel Dias Foundation (FUNED) is a prominent Brazilian public health institution and manufacturer based in Belo Horizonte, Minas Gerais. It serves as a critical pillar of Brazil's national health system, specializing in the production of hyperimmune sera (antivenoms), vaccines, and generic medications. FUNED also functions as a central state laboratory for epidemiological and environmental surveillance, while conducting extensive research and development in biotechnology and molecular biology. The foundation is one of the primary suppliers of essential biological products to the Brazilian Ministry of Health, particularly for the treatment of venomous animal accidents and infectious diseases. Additionally, it plays a vital role in the production of medications for the Brazilian Unified Health System (SUS), including treatments for leprosy and HIV.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ezequiel Dias Foundation.